4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof

Details for Australian Patent Application No. 2001273349 (hide)

Owner AMR Technology, Inc.

Inventors Pechulis Jr., Anthony D.; Beck, James P.; Harms, Arthur E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001273349

PCT Pub. Number WO02/04455

Priority 60217412 11.07.00 US

Filing date 11 July 2001

Wipo publication date 21 January 2002

Acceptance publication date 3 May 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4741 (2006.01)

A61K 31/4743 (2006.01)

A61K 31/4745 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 May 2004 Assignment before Grant

  Bristol Myer Squibb Pharma Company The application has been assigned to Albany Molecular Research, Inc. 2002

30 June 2005 Assignment before Grant

  Albany Molecular Research, Inc. The application has been assigned to AMR Technology, Inc.

3 May 2007 Application Accepted

  Published as AU-B-2001273349

6 September 2007 Standard Patent Sealed

6 October 2011 Assignment Registered

  AMR Technology, Inc. The patent has been assigned to Albany Molecular Research, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273350

2001273348